Colorectal cancer (CRC) is one of the most prevalent cancers, with more than one million
new cases every year. In the last few decades, several advancements in therapeutic and …

Simple Summary Colorectal cancer (CRC) is one of the most prevalent cancers worldwide.
Due to the absence of specific early symptoms, most of CRC patients are often diagnosed at …

Background A major challenge in stage II colorectal carcinoma is to identify patients with
increased risk of recurrence. Biomarkers that distinguish patients with poor prognosis from …

Breast cancer is a heterogeneous disease involving complex interactions of biological
processes; thus, it is important to develop therapeutic biomarkers for treatment. Members of …

Background: Natural killer (NK) cells are crucial components of the innate immune system
that fight tumors and viral infections. Patients with colorectal cancer (CRC) have a poor …

Colorectal cancer (CRC) has the fourth-highest incidence of all cancer types, and its
incidence has steadily increased in the last decade. The general transcription factor III …

Complex interactions in tumor microenvironment between ECM (extra-cellular matrix) and
cancer cell plays a central role in the generation of tumor supportive microenvironment. In …

Accurate and integral cellular DNA replication is modulated by multiple replication‐
associated proteins, which is fundamental to preserve genome stability. Furthermore …

Background: Colorectal cancer (CRC) ranks the second malignancy with high incidence and
mortality worldwide. Cancer stem cells (CSCs) function critically in cancer progression and …

Ferroptosis is a type of programmed cell death potentially playing an important role in
colorectal cancer (CRC) development. However, comprehensive investigations toward …